Bal Pharma stock hits upper circuit on affordable Favipiravir launch
The scrip hit upper circuit of 5 per cent to Rs 98.40 on Tuesday. The counter was settled at Rs 93.75 in the previous session. BSE Sensex was trading 148.79 points or 0.29 per cent up at 50,800.69.